THE Health Department said on Tuesday it had assigned an inspector to ascertain whether the consignment imported by the Medicines Sans Frontiers complied with its authorisation terms. The company was last year granted permission by the Medicines Control Council to import five generic drugs that were not registered in South Africa in terms of section 21 of the Medicines and Related Substances Control Act. It was allowed to procure lamivudine, Nevirapine, zidovudine, dinanosine and stavudine for clinical trial by two researchers. ”There are specific conditions under which these drugs should be used and these provisions specified by the MCC related mainly to issues of safety and proper monitoring,” the department said in a statement. The conditions included progress reports that should be submitted to the MCC every six months. – Sapa